Compliance Concerns: Laboratory Regulations in 2024 and Beyond
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025
From - G2 Compliance Advisor
While still facing serious sanctions from CMS, Theranos has been taking steps to rehabilitate its compliance image. The company announced the appointment of…
From - G2 Compliance Advisor
In the last two issues of Lab & Pathology Insider we highlighted new developments concerning the False Claims Act (FCA): the U.S. Supreme Court decision recognizing the…
From - G2 Compliance Advisor
Both the Centers for Medicare & Medicaid Services (CMS) and some high ranking Democratic Committee members had some bad news for…
From - G2 Compliance Advisor
Amidst the guilty pleas and sentencing of dozens of individuals, the laboratory company Biodiagnostic Laboratory Services LLC (BLS) entered a…
From - G2 Compliance Advisor
Nearly a year to the day after another nationwide Strike Force takedown, the Department of Justice announced last week what it says is a…